Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine

Acta Neurochir (Wien). 2021 Aug;163(8):2359-2362. doi: 10.1007/s00701-021-04860-w. Epub 2021 Jun 8.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology, the Pfizer/BioNTech vaccine is one of the vaccines been approved by the Drug Control Authority in Malaysia. Herein, we report an immediate complication of cerebral VST after the first dose of the Pfizer/BioNTech vaccine.

Keywords: Acute respiratory syndrome coronavirus 2; Cerebral venous sinus thrombosis; Coronavirus disease 2019.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Sinus Thrombosis, Intracranial / chemically induced*
  • Sinus Thrombosis, Intracranial / diagnostic imaging*
  • Time Factors
  • Vaccines, Synthetic / adverse effects*
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic